Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Lucid Diagnostics Inc. (LUCD)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 36,811,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Lucid Diagnostics is a commercial-stage medical diagnostics technology company focused on patients with gastroesophageal reflux (GERD) disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). Co.'s lead products, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell Collection Device in a noninvasive office procedure, serving as a screening tool to prevent EAC deaths, through early detection of esophageal precancer and cancer in at-risk GERD patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 700,000 700,000 700,000 700,000
Total Buy Value $915,214 $915,214 $915,214 $915,214
Total People Bought 1 1 1 1
Total Buy Transactions 6 6 6 6
Total Shares Sold 0 0 0 37,781
Total Sell Value $0 $0 $0 $54,809
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 6
End Date 2025-03-13 2024-12-10 2024-06-11 2023-06-12

   
Records found: 44
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Matheis Dennis Director   –       •      –    2025-05-22 4/A B $1.32 $43,795 D/D 33,218 565,443 2.39     -
   Matheis Dennis Director   –       •      –    2025-05-22 4 B $1.32 $43,795 D/D 33,218 350,000 2.39     -
   Matheis Dennis Director   –       •      –    2025-05-21 4/A B $1.32 $171,520 D/D 129,684 532,225 2.39     -
   Matheis Dennis Director   –       •      –    2025-05-21 4 B $1.32 $171,520 D/D 129,684 316,782 2.39     -
   Matheis Dennis Director   –       •      –    2025-05-20 4/A B $1.30 $242,292 D/D 187,098 402,541 2.39     -
   Matheis Dennis Director   –       •      –    2025-05-20 4 B $1.30 $242,292 D/D 187,098 187,098 2.39     -
   Lapidus Stanley Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 214,392     -
   Cox James L Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 282,120     -
   Aklog Lishan Chief Executive Officer   •       •      –    2025-02-20 4 A $0.00 $0 D/D 300,000 1,466,627     -
   Gordon Michael Adam General Counsel and Secretary   •       –      –    2025-02-20 4 A $0.00 $0 D/D 300,000 700,000     -
   Sparks Ronald M Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 197,460     -
   White Debra Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 112,800     -
   Oneil Shaun President and COO   •       –      –    2025-02-20 4 A $0.00 $0 D/D 300,000 826,763     -
   Sokolov Jacque J Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 197,460     -
   Matheis Dennis Director   –       •      –    2025-02-20 4 A $0.00 $0 D/D 112,800 162,725     -
   Mcgrath Dennis M Chief Financial Officer   •       –      –    2025-02-20 4 A $0.00 $0 D/D 300,000 1,343,569     -
   Aklog Lishan Chief Executive Officer   •       •      –    2024-05-07 4 A $0.00 $0 D/D 400,000 1,166,627     -
   Mcgrath Dennis M Chief Financial Officer   •       –      –    2024-05-07 4 A $0.00 $0 D/D 400,000 1,043,569     -
   Gordon Michael Adam General Counsel and Secretary   •       –      –    2024-05-07 4 A $0.00 $0 D/D 400,000 400,000     -
   Oneil Shaun President and COO   •       –      –    2024-05-07 4 A $0.00 $0 D/D 400,000 526,763     -
   Matheis Dennis Director   –       •      –    2024-05-06 3 IO $0.00 $0 D/D 0 49,925     -
   Pavmed Inc. 10% Owner   –       –       •   2024-02-15 4 D $0.00 $0 D/D (3,331,747) 31,302,444     -
   Pavmed Inc. 10% Owner   –       –       •   2024-01-26 4 A $1.40 $4,675,474 D/D 3,331,771 34,634,191     -
   Lapidus Stanley Director   –       •      –    2023-09-26 4 AS $1.43 $43,173 D/D (29,747) 101,592     -
   Lapidus Stanley Director   –       •      –    2023-09-25 4 AS $1.43 $286 D/D (200) 131,339     -

  44 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed